3rd Quarter - Report

THE NORMANDY GROUP, LLC for GENENTECH

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Agriculture AGR

Review of Food & Drug Administration regulation policies.

LobbyistCovered position, as disclosed
HENRY BONILLA Member, US House of Representatives
CHRISTINE PELLERIN —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Monitor legislation regarding brand name and generic pharmaceutical agreements, patent fees, and post-grant review reforms.

LobbyistCovered position, as disclosed
KRISTA STARK StafAsstLegAsstLegDirectorR.Sensenbrenner

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.